Table 3 Changes in anthropometric, biological, and blood pressure outcomes by treatment condition (n = 296)
Variable | SIPsmartER | Move More | Relative effects between conditionsb | ||||
|---|---|---|---|---|---|---|---|
Base-linea | 6Â montha | Adjusted change baseline to 6Â monthb | Base-linea | 6Â montha | Adjusted change baseline to 6Â monthb | ||
Body Mass Index (BMI), kg/m2 | 33.26 (9.28) | 33.05 (9.23) | −0.21 (−0.35, −0.06)** | 32.74 (8.98) | 32.84 (9.08) | 0.10 (−0.09, 0.30) | −0.31 (−0.55, −0.07)* |
Weight, kg | 90.7 (26.4) | 90.2 (26.4) | −0.5 (−0.9, −0.0)* | 90.4 (24.3) | 90.5 (24.7) | 1.0 (−0.2, 0.4) | −0.6 (−1.1, −0.1)* |
Cholesterol, mg/dL | 162.9 (38.2) | 155.5 (36.6) | −7.4 (−14.3, − 0.5)* | 168.7 (36.4) | 163.3 (32.4) | −5.4 (−13.2, 2.4) | −2.0 (−9.4, 5.3) |
Low-density lipoprotein (LDL) cholesterol, mg/dL | 95.3 (32.2) | 90.4 (29.5) | −4.9 (−9.2, −0.7)* | 99.9 (31.7) | 95.2 (30.7) | −4.8 (−9.2, −0.4)* | −0.1 (−5.6, 5.4) |
High-density lipoprotein (HDL) cholesterol, mg/dL | 45.5 (15.2) | 43.0 (15.0) | −2.6 (−5.3, 0.2) | 46.5 (14.9) | 45.0 (16.0) | −1.6 (−4.8, 1.7) | −1.0 (−4.4, 2.4) |
Triglycerides, mg/dL | 126.2 (77.3) | 125.0 (75.4) | −1.2 (−10.6, 8.2) | 128.6 (75.6) | 127.5 (70.2) | −1.1 (−8.5, 6.4) | −0.1 (−12.4, 12.2) |
Glucose, mg/dL | 80.3 (26.2) | 77.1 (26.7) | −3.2 (−6.6, 0.2) | 77.1 (24.0) | 74.8 (18.0) | −2.4 (−8.0, 3.2) | −0.8 (−3.6, 2.0) |
Systolic blood pressure, mm Hg | 123.3 (18.0) | 122.7 (17.6) | −0.6 (−3.9, 2.7) | 120.7 (13.3) | 121.0 (15.4) | 0.3 (−2.6, 3.2) | −0.9 (−3.6, 1.8) |
Diastolic blood pressure, mm Hg | 79.5 (11.7) | 80.0 (12.3) | 0.54 (−1.0, 2.1) | 79.7 (10.6) | 79.8 (11.0) | 0.1 (−1.3, 1.5) | 0.4 (−0.8, 1.6) |